Myeloma, Plasma-Cell clinical trials at University of California Health
1 in progress, 0 open to eligible people
Showing trials for
Study of BMF-219, in Adult Patients With Acute Leukemia, Diffuse Large B-Cell Lymphoma and Multiple Myeloma
Sorry, not currently recruiting here
A Phase1 first-in-human dose-escalation and dose-expansion Study of BMF-219, an Oral irreversible menin Inhibitor, in adult patients With acute leukemia, diffuse large B-cell lymphoma, and multiple myeloma
at UCLA
Last updated: